Parasitology Today 1993: Vol 9 Index

17 Pages·1993·5.4 MB·English

PARAS LTOLO GY
ay
CO
Subject Index
Author Index
Books Reviewed
1993
Vol 9
Issues 1—12
ISSN 0169 4758
Parasitology today
Elsevier Trends Journals
68 Hills Road
Cambridge
UK, CB2 ILA
Tel [phone]
Fax [phone]
Editorial Board A. E. Bianco, Liverpool School of Tropical Medicine, UK
D. A. P. Bundy, University of Oxford, UK
F. E. G. Cox, Kings College, London, UK
P. H. David, Institut Pasteur, Paris, France
C. Frasch, University of Buenos Aires, Argentina
S. Goldenberg, Fundagao Oswaldo Cruz, Brazil
S. L. James, National Institutes of Health, Bethesda, USA
C. |. Newbold, John Radcliffe Hospital, Oxford, UK
M. Pinder, IIRSDA, Abidjan, Céte d'Ivoire
J. Ribeiro, Univeristy of Arizona, Tucson, USA
D. G. Russell, Washington University Medical Center, St Louis, USA
G. Smith, University of Pennsylvania, USA
I. Tada, Kyushu University Medical School, Japan
M. Tanner, Swiss Tropical Institute, Switzerland
A. J. Trees, Liverpool School of Tropical Medicine, UK
P. J. Waller, CSIRO McMaster Laboratory, Glebe, Australia
Y. Yuthavong, Mahidol University, Thailand
Editor Theresa Saklatvala
Assistant Editor Sally Hirst
Publisher Peter Desmond
© 1994 Elsevier Science Ltd
All rights reserved. No part of this publication may be translated, reproduced, stored in an electronic
retrieval system, published or transmitted, in any form or by any means, such as, but not limited to,
electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the oe
copyright owner and the publisher, Elsevier Trends Journals, 68 Hills Road, Cambridge, UK CB2 ILA.
Author Index
BR — Book Review
L — Letter
A Boreham, P.F.L. and Stenzel, D.J., The de Castro, J.J. and Newson, R.M., Host
Aksoy, S., see Beard, C.B. 179
Current Status of Blastocystis Resistance in Cattle Tick Control
Ambroise-Thomas, P. and Pelloux, H., hominis (L)251 13
Toxoplasmosis — Congenital and in
Brabin, L., Trypanosoma cruzi Infection de Vlas, S.J., Gryseels, B.,
Immunocompromised Patients: A inWomen_ 198 van Oortmarssen, G.J., Polderman,
Parallel 61 Braga, L.L., see Petri, W.A. 73 A.M. and Habbema, J.D.F., A
Archer, S., see Cioli, D. 162 Braun Breton, C. and Pereira da Silva, Pocket Chart to Estimate True
Arese, P., see Turrini, F. 297 L.H., Malaria Proteases and Red Schistosoma mansoni Prevalences
Ash, C.P.J., Molecular Parasitology in Blood Cell Invasion 92 305
Brazil 113 Braun, R., see Smith, N. 236 del Portillo, H.A., see Perez, H.A. 351
Brophy, P.M. and Pritchard, D.L, Descoteaux, A. and Turco, S.J., The
Immunity to Helminths: Reply Lipophosphoglycan of Leishmania
B (L) 128 and Macrophage Protein Kinase C
Bacchi, C., Resistance to Clinical Drugs
Brown, G., see Roberts, D. 281 468
in African Trypanosomes 190 Brun, R., see Lun, Z-R. 41 Dias Neto, E., see Johnston, D.A. 286
Baird, A.W. and O’Malley, K.E., Bryant, C., Organic Acid Excretion by Diggs, C.L., Ballou, W.R. and Miller,
Epithelial lon Transport — Possible
Helminths 58 L.H., The Major Merozoite Surface
Contribution to Parasite Expulsion Bryceson, A.D.M., see Olliaro, P.L. Protein as a Malaria Vaccine Target
141 323 300
Baker, J., Mosquito Nets or Bednets? Bundy, D.A.P., see Grencis, R.K. 309 Dixon, D.M. and Martin, R.J., Patch-
(L) 217 Butcher, G., Host—Parasite Diplomacy Clamp and Chloride Channels in
Bakker-Grunwald, T. and Wéstmann, 275 Ascaris suum 341
C., Entamoeba histolytica as a Model Buxton, D., Toxoplasmosis: the First Dubey, J.P. and Lindsay, D.S.,
for the Primitive Eukaryotic Cell Commercial Vaccine 335 Neosporosis 452
27 Dupouy-Camet, J., Robert, F. and Soulé,
Ballou, W.R., see Diggs, C.L. 300
C., RAPD in the Genus Trichinella
Bancroft, A.J., see Grencis, R.K. 309 ia (L) 463
Barbet, A.F. and Kamper, S.M., The
Carter, N., The Chemotherapy of Human
Importance of Mosaic Genes to
Parasitic Disease (BR) 433
Trypanosome Survival 63 Chapman, H.D., Resistance to E
Barker, R.H., PCR Protocols: Current Anticoccidial Drugs in the Fowl Eberhard, M.L., see Hightower, A.W.
Methods and Applications (BR) 478 159 418
Barrett, A.J., see Luaces, A.L. 69 Charlwood, D., A Mosquito Net by Eckert, J., see Smith, N. 236
Barthold, S.W., see Fikrig, E. 129 Any Other Name_ (L) 128 Eichinger, D., see Schenkman, S. 218
Bates, P.A., Axenic Culture of Cioli, D., Pica-Mattoccia, L. and Archer, Eisemann, C.H., see Willadsen, P. 132
Leishmania Amastigotes 143 S., Drug Resistance in Elford, B. and Ferguson, D.J.P.,
Baylis, H.A., see Hall, R. 310 Schistosomes 162 Secretory Processes in Plasmodium
Baylis, M., Feeding Success of Vectors Clark, C.G., see Petri, W.A. 73 80
on Infected Hosts: Reply (L) 464 Clark, C.G., Speciation and Clonality in Elmendorf, H.G. and Haldar, K.,
Beales, P.F., see Schapira, A. 168
Entamoeba histolytica (L) 293 Secretory Transport in Plasmodium
Beard, C.B., O’Neill, S.L., Tesh, R.B., Constantine, C.C., see Thompson, 98
Richards, F.F. and Aksoy, S.,
R.C.A. 431 Else, K.J., see Grencis, R.K. 309
Modification of Arthropod Vector
Cooper, J.A., Merozoite Surface Engstler, M. and Schauer, R., Sialidases
Competence via Symbiotic Bacteria Antigen-1 of Plasmodium 50 from African Trypanosomes 222
179 Creasey, A.M., see Robson, K.J.H. (L) Evans, D. and Guyatt, H., Science of
Beier, J.C., Malaria Sporozoites: 127 Economics: Reply (L) 215
Survival, Transmission and Crisanti, A., see Muller, H-M. 261
Disease Control 210 Crompton, D.W.T., see Hochberg, M.E.
Bell, R.G., Intestinal Helminth 399 F
Expulsion (L) 351 Curtis, C.F., Mosquito Ecology: Field Fang, Y., see Lun, Z-R. 41
Bennett, J., Science of Economics (L) Sampling Methods (2nd edn) (BR) Faubert, G.M., Metronidazole and Drug
215 346 Resistance (L) 417
Bermudes, D. and Joiner, K.A., The Ferguson, D.J.P., see Elford, B. 80
Role of Parasites in Generating
D Ferrante, A., see Kumaratilake, L.M.
Evolutionary Novelty 458 D’ Andrea, A., see Trinchieri, G. (L) 97 (L) 56
Biggs, B-A., see Roberts, D. 281 Dalton, J.P., McNally, J. and Fikrig, E., Kantor, F.S., Barthold, S.W.
Billingsley, P., ‘Concealed’ Antigens: O'Donovan, S.M., Techniques and Flavell, R., Protective
Expanding the Range of Used to Study Erythrocyte Immunity in Lyme borreliosis 129
Immunological Targets (L) 334
Invasion by Malaria Parasites 109 Flavell, R., see Fikrig, E. 129
Blaxter, M., Nematode Parasites of Dame, J.B. and Blouin, M.S., Migration, Focks, D., A Colour Atlas of Medical
Vertebrates: Their Development and Selection and Population Size in Entomology (BR) 478
Transmission (BR) 146 Ostertagia ostertagi: Reply (L)55 Fox, M.T., Ectoparasites and Vectors of
Blaxter, M., Nemoglobins: Divergent (erratum, 128) Veterinary Importance 437
Nematode Globins 353 David, J.R., MIFasaGST 315
Blouin, M.S., see Dame, J.B. (L)55 David, J.R. and Harn, D.A.,
Blum, J.J., Intermediary Metabolism in Immunology and Molecular G
Leishmania 118 Biology of Tropical Infectious Gasser, R.B., see Thompson, R.C.A.
Boothroyd, J.C., see Sibley, L.D. 392 Diseases 349 431
Gatrill, A., The Natural Killer Cell (BR) Caenorhabditis elegans Daf-c Leitch, G.J., Visvesvara, G.S. and He,
307 Paradigm 23 Q., Inhibition of Microsporidian
Geary, T.G., see Thompson, D.P. 31 Howard, R.J. and Pasloke, B.L., Target Spore Germination 422
Gettinby, G., The Epidemiology of Antigens for Asexual Malaria Levin, M.J., Vazquez, M., Kaplan, D.
Theileriosis in Africa (BR) 272 Vaccine Development 369 and Schijman, A.G., The
Goday, C. and Pimpinelli, S., The Hudson, A.T., Atovaquone — A Novel Trypanosoma cruzi Ribosomal P
Occurrence, Role and Evolution of Broad-spectrum Anti-infective Protein Family: Classification and
Chromatin Diminution in Drug 66 Antigenicity 381
Nematodes 319 Hviid, L. and Theander, T.G., Seasonal Levitt, A., RNA Processing in Malarial
Graf, J-F., The Role of Insect Growth Changes in Human Immune Parasites 465
Regulators in Arthropod Control Responses to Malaria 26 Lewis, F.A., see Richards, C.S. (L) 217
471 Lindsay, D.S., see Dubey, J.P. 452
Grafen, A. and Woolhouse, M., Does Lindsay, S.W., 200 Years of Lice in
the Negative Binomial Distribution J Glasgow — an Index of Social
Add Up? 475 Jackson, G.J., Thoughts on the Deprivation 412
Grencis, R.K., Else, K.J., Bancroft, A.J. Entrapment of Nematodes by Locksley, R.M., see Reiner, S.L. 258
and Bundy, D.A.P., Trichuris Fungi (L) 352 L6pez-Romero, E. and Villagémez-
Update ‘93 309 James, A.A., The Biology of Mosquitos Castro, J.C., Encystation in
Grenvold, J., Wolstrup, J., Nansen, P. (Vol. 1): Development, Nutrition and Entamoeba invadens 225
and Henriksen, S.A., Nematode- Reproduction (BR) 147 Louis, J., see Milon,G. 196
trapping Fungi against Parasitic James, S., Immunity to Helminths (L) Luaces, A.L., Osorio, L.M. and Barrett,
128
Cattle Nematodes 137 A.J., A New Test for Infection by
Gryseels, B., see de Vlas, S.J. 305 Janse, C.J., Chromosome Size Entamoeba histolytica 69
Guillén, N., Cell Signaling and Motility Polymorphism and DNA Lucas, S., Molecular and Cell Biology of
in Entamoeba histolytica 364 Rearrangements in Plasmodium 19 Opportunistic Infections in AIDS
Guy, M.W., Entomological Field Jarne, P., Resistance Genes at the (BR) 345
Techniquefso r Malaria Control: Parts Population Level (L) 216 Lun, Z-R., Fang, Y., Wang, C-J. and
I&II (BR) 111 Jiang, J-B. and He, J-G., Taxonomic Brun, R., Trypanosomiasis of
Guyatt, H., see Evans, D. (L)215 Status of Blastocystis hominis 2 Domestic Animals in China 41
Johnson, P.J., Metronidazole and Drug Lustigman, S., Molting, Enzymes, and
Resistance 183 New Targets for Chemotherapy in
H Johnston, D.A., Dias Neto, E., Simpson, Onchocerca volvulus 294
Habbema, J.D.F., see de Vlas, S.J. 305 A.J.G. and Rollinson, D., Opening Lymbery, A., Migration, Selection and
Hagan, P. and Wilkins, H.A., the Can of Worms: Molecular Population Size in Ostertagia
Concomitant Immunity in Analysis of Schistosome ostertagi 37
Schistosomiasis 3 Populations 286 Lymbery, A., Migration, Selection and
Haldar, K., see Elmendorf, H.G. 98 Joiner, K.A., see Bermudes, D. 458 Population Size in Ostertagia
Hall, R. and Baylis, H.A., Tropical ostertagt: Reply (L)55
Theileriosis 310 Lymbery, A.J., see Thompson, R.C.A.
Halloran, M.E., see Schapira, A. 168 K 313
Harn, D.A., see David, J.R. 349 Kamper, S.M., see Barbet, A.F. 63
Hawdon, J., see Hotez, P. 23 Kantor, F.S., see Fikrig, E. 129
Hay, J., see Sims, T.A. (L) 292 Kaplan, D., see Levin, M.J. 381 M
He, J-G., see Jiang, J-B. 2 Katz, A. and Walgate, R., TDR: New Mann, B.J., see Petri, W.A. 73
He, Q., see Leitch, G.J. 422 Targets and Management Structure Martin, R.J., see Dixon, D.M. 341
Hecker, H., Man and Sea Urchin - 439 Martin, S.K., Chloroquine-resistant
More Closely Related than African Kennedy, M.W., see McReynolds, L.A. Plasmodium falciparum and the
and American Trypanosomes? 403 MDR Phenotype 278
(L) 57 Kierszenbaum, F., see Sztein, M.B. 424 McConville, M.J. and Schneider, P.,
Hennessy, D.R., Pharmacokinetic Knight, M., see Richards, C.S. (L) 217 Conservation of Surface Molecules
Disposition of Benzimidazole Koella, J.C., Epidemiological Evidence of Trypanosomatids 316
Drugs in the Ruminant for an Association between McCutchan, T.F., see Waters, A.P. 246
Gastrointestinal Tract 329 Chloroquine Resistance of McNally, J., see Dalton, J.P. 109
Henriksen, S.A., see Gronvold, J. 137 Plasmodium falciparum and its McReynolds, L.A., Kennedy, M.W. and
Higgins, D.G., see Waters, A.P. 246 Immunological Properties 105 Selkirk, M.E., The Polyprotein a
Higgs, S., Powers, A.M. and Olson, Konishi, E., Naturally Occurring Allergens of Nematodes 403
K.E., Alphavirus Expression Antibodies that React with Medley, G.F., Mathematical Models of
Systems: Applications to Mosquito Protozoan Parasites 361 Tick-borne Disease Transmission:
Vector Studies 444 Kubin, M., see Trinchieri, G. (L) 97 Reply (L)292
Hightower, A.W., Lammie, P.J. and Kumaratilake, L.M. and Ferrante, A., Mehlotra, R.K., Surface Properties,
Eberhard, M.L., Maternal Filarial Unravelling the Cytokine Network Pathogenicity and Differentiation
Infection — A Pertinent Risk Factor in Malaria: Reply (L) 56 of Entamoeba histolytica (L) 216
for Microfilaremia in Offspring? Kyes, S., see Wooden, J. 303 Meltzer, M.I. and Norval, R.A.L,
418 Mathematical Models of Tick-
Ho, N.F.H., see Thompson, D.P. 31 borne Disease Transmission 277
Hochberg, M.E. and Crompton, D.W.T., L Mertens, E., ATP Versus
Franco-Britannic Meeting on Lammie, P.J., see Hightower, A.W. Pyrophosphate: Glycolysis
Host—Parasite Co-evolution 399 418 Revisited in Parasitic Protists 122
Holden-Dye, L. and Walker, R.J., Langsley, G., Global Infectious Diseases: Meshnick, S.R., International Congress
5-Hydroxytryptamine and Motility Prevention, Control and Eradication for Tropical Medicine and Malaria
in Fasciola hepatica 339 (BR) 232 195 |
Hotez, P., Hawdon, J. and Schad, G.A., Lehane, M.]., see Miller, N. 45 Michael, E., Mathematical Modelling of
Hookworm Larval Infectivity, Lehmann, T., Ectoparasites: Direct Disease Epidemiology 397
Arrest and Amphiparatenesis: The Impact on Host Fitness 8 Milhous, W.K., see Schuster, B.G. 167
Miller, L.H., see Diggs, C.L. 300 American Scientists Meet at Resistance 174
Miller, N. and Lehane, M.J., Peritrophic Caracas 351 Royce, L., Principles of Acarology (BR)
Membranes, Cell Surface Perlmann, P., see Troye-Blomberg, M. 345
Molecules and Parasite Tropisms (L)1 8 Russell, D.G., see Webster, P. 201
within Arthropod Vectors 45 Perry, R., Plant Disease Control (BR)
(erratum, 128) 233 S
Milon, G. and Louis, J., CD8* Cells and Petersen, C., Cellular Biology of Schad, G.A., see Hotez, P. 23
Immunity to Intracellular Cryptosporidium parvum 87 Schapira, A., Beales, P.F. and Halloran,
Pathogens 196 Petri, W.A., Clark, C.G., Braga, L.L. and M.E., Malaria: Living with Drug
Morzaria, S.P., see Musoke, A.J. 385 Mann, B.]J., International Seminar Resistance 168
Morzaria, S.P. and Young, J.R., Genome on Amebiasis 73 Schauer, R., see Engstler, M. 222
Analysis of Theileria parva 388 Pfefferkorn, E.R., see Sibley, L.D. 392 Schenkman, S. and Eichinger, D.,
Miller, H-M., Ranucci, L., Pozio, E. and Phillips, R.S., see Taylor-Robinson, A.J. 1 Trypanosoma cruzi Trans-sialidase
Crisanti, A., A Method for Pica-Mattoccia, L., see Cioli, D. 162 and Cell Invasion 218
Collecting Large Quantities of Pimpinelli, S., see Goday, C. 319 Schijman, A.G., see Levin, MJ. 381
Cryptosporidium Parasites 261 Polderman, A.M., see de Vlas, S.J. 305 Schlein, Y., Leishmania and Sandflies:
Munn, E.A., Development of a Vaccine Powers, A.M., see Higgs, 5. 444 Interactions in the Life Cycle and
against Haemonchus contortus 338 Pozio, E., see Muller, H-M. 261 Transmission 255
Murrell, K.D., see Zarlenga, D.S. (L) Prichard, R.K., Molecular Biology of Schneider, P., see McConville, M.].
250 Free Living and Parasitic 316
Musoke, A.J., Nene, V. and Morzaria, Helminths 273 Schuster, B.G. and Milhous, W.K.,
S.P., A Sporozoite-based Vaccine Pritchard, D.I., see Brophy, P.M. (L) Reduced Resources Applied to
for Theileria parva 385 (erratum, 128 Antimalarial Drug Development
479) 167
N Schwarzer, E., see Turrini, F. 297
Nansen, P., see Grenvold, J. 137 R Selkirk, M.E., see McReynolds, L.A.
Nene, V., see Musoke, A.J. 385 Ramachandran, C.P., Improved 403 .
Newbold, C.I., see Roberts, D. 281 Immunodiagnostic Tests to Shahabuddin, M., Chitinase: a Novel
Newson, R.M., see de Castro, J.J. 13 Monitor Onchocerciasis Control Target for Blocking Parasite
Norval, R.A.1., see Meltzer, M.I. 277 Programmes — A Multicenter Effort Transmission? 252
76 Shevach, E.M., see Récken, M. 377
Randolph, S.E., see Rogers, D.J. 266 Shieh, J-N., see Rossignol, P.A. 442
O Ranucci, L., see Muller, H-M. 261 Shoop, W.L., Ivermectin Resistance — A
O’Donovan, S.M., see Dalton, J.P. 109 Reiner, S.L. and Locksley, R.M., The Review 154
O'Malley, K.E., see Baird, A.W. 141 Worm and the Protozoa: Sibley, C.H., see Wooden, J. 303
O'Neill, S.L., see Beard, C.B. 179 Stereotyped Responses or Distinct Sibley, L.D., Pfefferkorn, E.R. and
Olliaro, P.L. and Bryceson, A.D.M., Antigens? 258 Boothroyd, J.C., Development of
Practical Progress and New Drugs Rengaraju, M., see Trinchieri,G. (L) genetic Systems for Toxoplasma
for Changing Patterns of 97 Gondii 392
Leishmaniasis 323 Reynoldson, J.A., see Thompson, Simpson, A.J.G., see Johnston, D. A.
Olliaro, P. and Trigg, P.I., Antimalarial R.C.A. 313 286
Resistance and Health Policies Richards, C.S., Knight, M. and Lewis, Sims, S.M., see Thompson, D.P. 31
(L) 33 F.A., Resistance Genes at the Sims, T.A. and Hay, J., Recrudescence
Olson, K.E., see Higgs, S. 444 Population Level: Reply (L) 217 of Toxoplasma Infection (L) 292
Osorio, L.M., see Luaces, A.L. 69 Richards, F.F., see Beard, C.B. 179 Smith, N., Eckert, J. and Braun, R.,
Ouellette, M. and Papadopoulou, B., Robert, F., see Dupouy-Carnet, J. (L) Coccidiosis Research in Europe
Mechanisms of Drug Resistance in 463 236
Leishmania 150 Roberts, D., Biggs, B-A., Brown, G. and Sohnle, P., Candidiasis: Pathogenesis,
Newbold, C.L., Protection, Diagnosis and Treatment (2nd edn)
Pathogenesis and Phenotypic (BR) 434
P Plasticity in Plasmodium falciparum Soulé, C., see Dupouy-Carnet, J. (L)
Papadopoulou, B., see Ouellette, M. Malaria 281 (erratum, 428) 463
150 Robertson, I.D., see Thompson, R.C.A. Stanley, S.L. and Virgin IV, H.W., SCID
Parodi, A.J., Biosynthesis of Protein- 431 Mice as Models for Parasitic
linked Oligosaccharides in Robson, K.J.H., Walliker, D., Creasey, Infection 406
Trypanosomatid Flagellates 237 2 A.M. and Wilson, R.J.M., FCR-3, Stenzel, D.J., see Boreham, P.F.L. (L)
IFO
Pasloke, B.L., see Howard, R.J. 369 Chloroquine Resistance and Cross- 251
Patterson, J.L., The Current Status of contamination of Culture Lines of Stevenson, M.M., More on Unravelling
Leishmania RNA Virus 1 135 Plasmodium falciparum: Reply (L) the Cytokine Network in Malaria
Pawlowski, Z.S., Potential Eradication 127 (L) 333
of Taeniasis/Cysticercosis (L) 464 Récken, M. and Shevach, E.M., Do Sztein, M.B. and Kierszenbaum, F.,
Pays, J-F., Entamoeba dispar? (L) 292 Parasitic Infections Break T-cell Mechanisms of Development of
Pearce, E., Allergy and Immunity to Tolerance and Trigger Immunosuppression During
Helminths: Common Mechanisms or Autoimmune Disease? 377 Trypanosoma Infections 424
Divergent Pathways? (BR) 479 Rogers, D.J. and Randolph, S.E.,
Pellé, R., The Use of Electrophoretic Distribution of Tsetse Flies and
Profile of RNA to Differentiate Ticks in Africa: Past, Present and T
Trypanosoma brucei from Future 266 Taverne, J., Unravelling the Cytokine
r'rypanosoma congolense (L) 96 Rollinson, D., see Johnston, D.A. 286 Network in Malaria 38
Pelloux, H., see Ambroise-Thomas, P. Rossignol, P.A. and Shieh, J-N., Feeding Taylor-Robinson, A.W. and Phillips
6] Success of Vectors on Infected R.S., Anti-Malarial Antibodies in
Pereira da Silva, L.H., see Braun Breton, Hosts 442 Twins 1
C. 92 Roush, R.J., Occurrence, Genetics and Taylor-Robinson, A.W., Are Antibodies
Perez, H.A. and del Portillo, H.A., Latin Management of Insecticide Important in Mice Infected with
Plasmodium yoelii? (L) 96 U Cryptosporidium 263 (erratum,
Tellam, R.L., see Willadsen, P. 132 Upcroft, J.A. and Upcroft, P., Drug 322)
ter Kuile, B.H., Glucose and Proline Resistance in Giardia 187 Webster, P. and Russell, D.G., The
Transport in Kinetoplastids 206 Upcroft, J.A. and Upcroft, P., Flagellar Pocket of
Tesh, R.B., see Beard, C.B. 179 Metronidazole and Drug Trypanosomatids 201
Theander, T.G., see Hviid, L. 26 Resistance: Reply (L) 417 Wharton, D.A., Parasites of Economic
Thompson, D.P., Ho, N.F.H., Sims, $.M. Upcroft, P., see Upcroft, J.A. 187 Importance in New Zealand 438
and Geary, T.G., Mechanistic Upcroft, P., see Upcroft, J.A. (L) 417 Wilairat, P., see Yuthavong, Y. 241
Approaches to Quantitate Wilkins, H.A., see Hagan, P. 3
Anthelmintic Absorption by Willadsen, P., Eisemann, C.H. and
Gastrointestinal Nematodes 31 V Tellam, R.L., ‘Concealed’ Antigens:
Thompson, R.C.A., Reynoldson, J.A. Valiante, N.M., see Trinchieri, G. (L) Expanding the Range of
and Lymbery, A.J., Giardia —- from 97 Immunological Targets 132
Molecules to Disease and Beyond van Oortmarssen, G.]., see de Vlas, S.]. Wilson, M.L., Avermectins in
313 (erratum, 428) 305 Arthropod Vector Management —
Thompson, R.C.A., Robertson, I.D., Vazquez, M., see Levin, M.J. 381 Prospects and Pitfalls 83
Gasser, R.B. and Constantine, C.C., Venkatesan, P. and Wakelin, D., (erratum, 322)
Hydatid Disease in Western ELISAs for Parasitologists: or Lies, Wilson, R.J.M., see Robson, K.J.H. (L)
Australia: A Novel Approach to Damned Lies and ELISAs 228 127
Education and Surveillance 431 Villago6mez-Castro, J.C., see L6pez- Wolstrup, J., see Grenvold, J. 137
Tibayrenc, M., Clonality in Leishmania Romero, E. 225 Wooden, J., Kyes, S. and Sibley, C.H.,
(L) 58 Virgin IV, H.W., see Stanley, S.L. 406 PCR and Strain Identification in
Tibayrenc, M., Entamoeba, Giardia, Visvesvara, G.S., see Leitch, G.J. 422 Plasmodium falciparum 303
Toxoplasma: Clones or Cryptic Woolhouse, M., International
Species? 102 Conference on Schistosomiasis
Tibayrenc, M., Speciation and Clonality WwW 235
in Entamoeba histolytica: Reply (L) Wakelin, D., Allergic Inflammation as a Woolhouse, M., see Grafen, A. 475
293 Hypothesis for the Expulsion of Wostmann, C., see Bakker-Grunwald,
Trager, W., FCR-3, Chloroquine Worms from Tissues 115
Resistance and Cross- Wakelin, D., see Venkatesan, P. 228
contamination of Culture Lines of Wakelin, D., Intestinal Helminth
Plasmodium falciparum (L) 127 Expulsion: Reply (L) 352 Y
Trigg, P.I., see Olliaro, P. (L) 334 Walgate, R., see Katz, A. 439 Young, J.R., see Morzaria,S.P. 388
Trinchieri, G., Rengaraju, M., Walker, R.J., see Holden-Dye, L. 339 Yuthavong, Y. and Wilairat, P.,
D’ Andrea, A., Valiante, N.M. and Waller, P.J., Nematophagous Fungi: Protection against Malaria by
Kubin, M., Producer cells of Prospective Biological Control Thalassaemia and Haemoglobin
Interleukin 12 (L) 97 Agents of Animal Parasitic Variants 241
Troye-Blomberg, M. and Perlmann, P., Nematodes? 429
Anti-malarial Antibodies in Twins: Walliker, D., see Robson, K.J.H. (L)
Reply (L)18 127 Z
Turco, S.J., see Descoteaux, A. 468 Wang, C-J., see Lun, Z-R. 41 Zarlenga, D.S. and Murrell, K.D.,
Turrini, F., Schwarzer, E. and Arese, P., Waters, A.P., Higgins, D.G. and Biochemical Characterization
The Involvement of Hemozoin McCutchan, T.F., The Phylogeny of within the Genus Trichinella (L)
Toxicity in Depression of Cellular Malaria: a Useful Study 246 250
Immunity 297 Webster, K.A., Molecular Methods for Zierdt, C.H., Taxonomic Status of
the Detection and Classification of Blastocystis hominis: Reply (L) 18
vi
Subject Index
A distribution haemozoin toxicity depressing 297
abamectin 83ff and global warming 269 China
actin management, avermectins in 83ff trypanosomiasis of domestic animals
in Entamoeba histolytica 366 modification via symbiotic bacteria 41 ff
AIDS 179ff chitin
microsporidiosis 422ff parasite tropisms 45ff metabolism, Entamoeba spp 226ff
prevalence 195 peritrophic membranes in 45ff structure and properties 253
allergens Ascaris spp synthesis inhibitors 472ff
polyprotein, innematodes 403ff ABA-1 allergen 403 chitinase
allergic inflammation 115ff Ascaris suum parasite transmission and 252ff
allopurinol chloride channels 341ff structure and properties 253
in leishmaniasis 326 atovaquone 66ff chloride channels
allosamidin mode of action 67 in Ascaris suum 341ff
structure and properties 253 Australia, Western chloroquine
alphaviruses hydatid disease 431 immunological properties 105ff
expression systems 444ff autoimmune disease malaria costs and fatality rates 173
molecular biology 444 T-cell tolerance and 377ff resistance 105ff, 127 (L), 278ff
replicon systems 449ff autoimmunity chromatin diminution
Amblyomma spp 13 due to activation of tolerant T cells ciliates 321
amebae see amoebae 378f crustaceans 321
amebiasis see amoebiasis in parasitic diseases 379 insects 321
aminosidine avermectins nematodes 319ff
in leishmaniasis 326ff arthropod vector management 83ff vertebrates 321
amoebae indirect effects on pathogen chromosome size polymorphism
directional movement 365 transmission 85 Plasmodium spp 19ff
movement and host defense 368 non-target effects 85ff ciliates
amoebiasis resistance to 85, 154ff chromatin diminution 321
cell biology 75 structures 157 circumsporozoite protein release 211ff
ENZYMEBA test 70 sublethal effects 84ff clonality 102ff, 293 (L)
immunity 75 coccidial drugs
international seminar 73ff B alternation with vaccines 161
invasive/noninvasive strains 73ff bacteria, symbiotic coccidiosis
pathogenesis 74ff modifying arthropod vectors 179ff drug resistance 159ff
amphiparatenesis benzimidazole drugs immunology 236ff
hookworms 23ff pharmacokinetic disposition in molecular biology 237ff
amphotericin B ruminant gastrointestinal tract rabbit 238
in leishmaniasis 325ff 329ff research in Europe 236ff
anaemia biomathematics 398ff ruminants 239
Trypanosoma vivax sialidase in 222ff see also mathematical modelling concomitant immunity
ancylostomiasis Blastocystis hominis in schistosomiasis 3ff
control 23 taxonomic status 2ff, 18 (L), 251 (L) crustaceans
anthelmintics Boophilus microplus chromatin diminution 321
absorption 31ff ‘concealed’ antigens 132 cryptic species 102ff, 293 (L)
resistance 438 Borrelia burgdorferi 129ff Cryptosporidium spp
antibodies heterogeneity 130 classification 263ff
naturally occurring 361ff outer surface proteins 129ff detection 263ff
anticoccidial drugs vaccine candidates 129ff Cryptosporidium parvum
combinations of 161 Brazil antigens 89
crossresistance 160 molecular parasitology 113ff asexual invasive stages 88
multiple resistance 160ff buffaloes cell culture 87ff
resistance mechanisms 159ff trypanosomiasis 41ff cellular biology 87ff
resistance stability 161 collection of large quantities
antifolates C culture 261
resistance to 151ff Caenorhabditis elegans infectionin humans 263ff
antigens Daf-c paradigm 23ff infection in livestock 264
‘concealed’ 132ff, 334 (L) camels life cycle 88
variant surface 284 trypanosomiasis 44 monoclonal antibodies 264
antigiardial drugs 187ff cattle sexual stages 90
antimonials nematode-trapping fungi 137ff, structural proteins 91
pentavalent 150ff, 323ff 352 (L) cyromazine
arboviruses neosporosis 456 as insect growth regulator 473ff
interference to superinfection 449 trypanosomiasis 41ff cysteine proteinases 114
intracellular immunization 448ff cattle ticks cysticer/c toaesniiassi s
Arthrobotrys spp host resistance 13ff potential eradication (L) 464
in parasitic nematode control 429ff resistance assessment 16 cytokine network
Arthrobotrys oligospora CD4+* T cells in malaria 38ff, 56 (L) (L)
nematode trapping 137ff functional phenotypes 258ff cytoplasmic incompatibility 182
arthropod control CD8* T cells
insect growth regulators 471ff and immunity to intracellular D
arthropod vectors pathogens 196 dapsone
cell surface membranes in 45ff cellular immunity in leishmaniasis 328
DDT resistance 174ff encystation 225ff pyrophosphate-dependent 122ff
diamidine resistance 191ff enzyme-linked immunosorbent assay glycoproteins
disease transmission (ELISA) 228ff variant surface (VSG) 63ff
mathematical models 277ff, 292 (L) components 228 glyoxylate cycle
DL-alpha-difluoromethylornithine ENZYMEBA test for Entamoeba Leishmania spp 120
(DFMO) 192ff histolytica infection 69ff Golgi apparatus
DNA fingerprinting 289ff epidemiology processing of N-linked
DNA isolation mathematical modelling 397ff oligosaccharides in 374ff
Chelex-100 303 epithelial ion transport 141ff
DNA rearrangements eukaryotes H
Plasmodium spp 19ff evolution 29 haemoglobin
dogs model of primitive cell 27ff protection against malaria 241ff
neosporosis 455ff evolutionary novelty Haemonchus contortus
drug resistance role of parasites 458ff ‘concealed’ antigens 133
African trypanosomes 190ff vaccine development 338ff
anticoccidial drugs 159ff F haemozoin
crossresistance 160 facilitated diffusion nature of 297
by gene amplification 152ff transport kinetics 209 toxicity, in depression of cellular
genes (L)216 Fasciola hepatica immunity 297ff
giardiasis 187ff motility 339ff halofantrine
hycanthone/oxamniquine 162 FCR-3 isolate (L) 127 malaria costs and fatality rates 173
insecticides 174ff ferredoxin: oxidoreductase 184ff Harposporium anguillulae
ivermectin 154ff filaria nematode trapping 138
malaria 168ff, 195, 334 (L) chitinase in transmission 253ff helminths
management 149 ivermectin resistance 157ff control (L) 215
mechanisms 150ff, 175 filarial antigens expulsion from tissues 115ff
melarsoprol 191 in utero 419ff immunity to 128 (L)
metronidazole 183, 417 (L) filarial infection metabolism 34, 128 (L), 274
multiple 160ff, 278ff maternal, as risk factor in offspring molecular biclogy 273ff
schistosomes 162ff 418ff molecular pharmacology 274ff
stabilityo f 161 filarial nematodes neurobiology 273ff
dsSIN virus 446ff polyprotein allergens 403ff organic acid excretion 58ff
elucidating virus interference flow cytometry surfaces 273
mechanisms 449 Cryptosporidium detection 265 hemoglobin see haemoglobin
Duddingtonia spp fowl hemozoin see haemozoin
in parasitic nematode control 429ff resistance to anticoccidial drugs hookworms
159ff amphiparatenesis 23ff
E fungi arrested development 23
East Coast fever nematode-trapping 137ff, 352 (L) Dauer phenotype 24ff
immunity to 385ff host specificity basis 25
vaccine development 385ff G larval infectivity 23ff
see also Theileria parva; theileriosis gene amplification life history stages 24
echinococcosis see hydatid disease drug resistance by 152ff horses
ectoparasites genes trypanosomiasis 41ff
costs of host defence 9 resistance (L) 216 host-parasite systems
determinants of virulence 8ff genetics co-evolution 399ff
host fitness and _ 8ff extrachromosomal 113 diplomacy 275ff
Eimeria spp reverse 349 ectoparasites 8ff
drug resistance 159ff Giardia spp 313ff host resistance
endoplasmic reticulum control 314 in cattle tick control 13ff
processing of N-linked host—parasite relationships 314 hosts
oligosaccharides in 347ff species definition 313 infected, vector bias toward 442,
Entamoeba spp taxonomy 102ff 464 (L)
chitin metabolism 226ff Giardia duodenalis positive effects of parasites 462
clonality 102ff, 293 drug resistance 187ff types, definition 475ff
encystation 225ff giardiasis Hyalomma anatolicum 13
speciation 102ff, 293 (L) drug resistance 187ff hycanthone
taxonomy 102ff, 293 (L) global warming mechanism of action 163, 165
Entamoeba dispar (L) 292 and arthropod vector distribution resistance 162
Entamoeba histolytica 269 structure 163
cell signalling and motility 364ff globins hydatid disease
cytoskeletal rearrangements and divergent nematode 353ff education and surveillance 431ff
movement 365ff Glossina morsitans New Zealand 439
differentiation (L) 216 distribution in Africa 268ff Western Australia 431ff
directional movement 365 Glossina pallidipes Hydra spp
modelling primitive eukaryotic cell distribution in Africa 269 internalizing foreign particles 460
27ff glucose hydrogenosome 125
movement and host defense 368 transport in kinetoplastids 206ff 5-hydroxytryptamine, and motility in
pathogenicity (L) 216 glutathione S-transferase Fasciola hepatica 339f¢ |
phylogenic status 28 macrophage migration inhibitory
signal transduction regulation 367ff factoras 315ff I .
surface properties (L) 216 glycolysis immune dynamics
test for infection 69ff in parasitic protists 122ff mathematical modelling 397ff
Entamoeba invadens glycolytic enzymes immune response
Viil
malaria, seasonal changes 26ff chemotherapy 150ff malaria proteases
polarized 258ff cytokines in 38ff and red blood cellinvasion 92ff
immunity dapsone therapy 328 diversity 92
concomitant 3ff drug research 324 malarial parasites
roles of natural antibodies 363ff immunotherapy 327ff erythrocyte invasion, in vitro assays
immunodeficiency new drugs 323ff 109
gene knockout models 408 pentamidine therapy 325 mathematical modelling
SCID mice 406ff pentavent antimonials 323ff epidemiology 397ff
immunodiagnosis 350 treatment 324 see also biomathematics
immunosuppression mechanisms lice mefloquine
trypanosome infections 424ff and social deprivation 412ff malaria costs and fatality rates 173
insect growth regulators lipophosphoglycan melarsoprol
in arthropod control 471ff of Leishmania spp 468ff resistance 191ff
insecticide resistance logistic regression model 419, 420 trypanothione and 191
genetics 174ff Lucilia cuprina merozoite surface antigen-I
management 174ff ‘concealed’ antigens 132ff dimorphic model 52
insecticides 471 Lyme borreliosis epidermal growth factor-like domain
insects immunization 130ff 53
chromatin diminution 321 murine model 129 evolution 52
cytoplasmic incompatibility 182 protective immunity 129ff function 54
juvenile hormones 472 gene sequencing 51ff
symbiosis 180 M immunodominant epitopes 53ff
interleukin 2 macrophage migration inhibitory factor Plasmodium spp _ 50ff
T-cell tolerance and 377ff as glutathione S-transferase 315ff proteolytic cleavage 52
interleukin 10 349 macrophages merozoite surface protein
interleukin 12 349 inhibition of protein kinase C in amino acid sequence polymorphism
producer cells (L) 97 469ff 301
intracellular pathogens malaria as malaria vaccine target 300ff
immunity, and CD8* T cells 196ff antibodies, twin studies 1ff, 18 (L) processing 92ff
Isospora suis 239 antigens, soluble 370 merozoites, invasive 371
ivermectin resistance 154ff asexual, vaccine development 369ff in vitro assays 109
mechanisms 156 atovaquone therapy 66ff release of 93ff
side-resistance 156ff avian 247 metronidazole
tests for 156 chloroquine resistance 105ff current uses 188
see also avermectins clinical case-definitions guiding in giardiasis 187ff
therapy 6 mode of action 185
J control, sporozoite transmission and resistance 183, 417 (L)
juvenile hormones 213 selective activation 184, 417 (L)
ininsects 472 costs and fatality rates 173 mice
cytokine network in 38ff, 56 (L), severe combined immunodeficiency
K 333 (L) (SCID) 406ff
kinetoplastids drug costs 173 microfilaremia
glucose transport 206ff drug development resources 167ff age-specific prevalences 419
proline transport 206ff drug policies 169ff maternal filarial infection and 418ff
drug resistance 168ff, 195, 334 (L) microsporidia
L early classification schemes 246ff species infecting humans 423
Leishmania spp epidemiology 105ff spore germination 422ff
amino acid metabolism 120ff fatality rates 173 milbemycins
axenic culture of amastigotes 143ff health policies (L) 334 resistance to 154ff
chitinase in transmission 252ff immune mechanisms 244ff structures 157
clonality (L)58 immune responses 26ff mitochondria
drug resistance 150ff international congress 195 mRNAs, processing in malarial
fatty acid metabolism 120 management 169 parasites 467
glucose catabolism 118ff mathematical model for drug policy origin 462
glucose transport mechanisms 208ff decisions 172ff molecular parasitology
glucose uptake and storage 118 membrane surface antigens 371 Brazil 113ff
glyoxylate cycle 120 merozoite surface protein 300ff mosquito nets 128 (L), 217 (L)
Hlocus 151 pathogenesis 281 ff mosquitoes
interactions with Phlebotomus 255ff pharmaceutical neglect 167 alphavirus expression systems 444ff
intermediate metabolism 118ff phylogeny 246ff dsSIN virusin 446ff
life cycle 144 prevalence 167 multi-drug resistance 160ff, 278ff
lipophosphoglycan 468ff protection 241ff, 281ff multigene families 114
penetrating peritrophic membranes research 351 mutualism
49 RNA processing in parasites 465ff parasitism and 458ff
pentose-phosphate pathway 120 seasonal changes in immune myosin
promastigote culture 145ff responses 26ff in Entamoeba histolytica 366ff
RNA virus! 135ff sporozoites 210ff
ishmania donovani target antigens 369ff N
glucose transport 206ff therapeutic efficiency assessment test negative binomial distribution
proline transport 206ff 170 limits of applicability 475ff
shmaniasis transfection 350 nematode-trapping fungi 137ff,
allopurinol therapy 326 transmission, chitinase in 252ff 352 (L), 429ff
aminosidine therapy 326ff vaccine development 1f f, 349ff, nematodes
amphotericin B therapy 325ff 369ff chromatin diminution 319ff
evolution 353ff parasitology polymerase chain reaction
gastrointestinal, anthelmintic milestones in 347ff conditions for 304
absorption by 31ff patch-clamp technique 34/1ff Cryptosporidium detection 265
polyprotein allergens 403ff pentamidine diagnostics and 350
nemoglobins 353ff in leishmaniasis 325 identification of P. falciparum strains
cladogram 357 pentavalent antimonials 150ff 303f f
evolution 353ff pentose-phosphate pathway polyprotein allergens
functions 357ff Leishmania spp 120 nematodes 403ff
gene duplications 354 peritrophic membranes population genetics 37ff, 55 (L)
mobile introns 354 in arthropod vectors 45ff proline
taxonomic distribution 356 Pf155/RESA 1ff transport in kinetoplastids 206ff
Neospora spp Phlebotomus spp protein kinase C
bovine isolates 457 interactions with Leishmania 255ff lipophosphoglycan-inhibiting
Neospora caninum 452ff life cycle 255ff activity 468ff
host-parasite relation 453ff phosphoenolpyruvate protists
in vitro cultivation 453 carboxytransphosphorylase 123ff glycolysis 122ff
life cycle 452 phosphofructokinase 122ff protozoa
structure 452 pyrophosphate-dependent 122ff and worms 258ff
neosporosis 452ff pigs Psoroptes spp
cattle 456 Isospora suis 239 phenotypic variation 437
diagnosis 454ff Plasmodium spp pyrophosphate-acetate kinase 124
dogs 455ff chitinase in transmission 252 pyrophosphate-dependent
New Zealand chromosome size polymorphism phosphofructokinase (PPi-PFK)
economically important parasites 19ff 122ff
438f f cytokines and 38ff, 56 (L), 333 (L) pyrophosphate metabolism 122ff
nitric oxide DNA rearrangements 19ff pyruvate phosphate dikinase 123
protective response 276 genome organization 19
host-parasite diplomacy 275ff R
O merozoite surface antigen-I 50ff rabbits
oligosaccharides penetrating peritrophic membranes coccidiosis 238
biosynthesis in trypanosomes 373ff 47ff random amplified polymorphic DNA
structures 373 phylogenetic tree 249 289
Onchocerca volvulus RNA processing 465ff in Trichinella spp (L) 463
chemotherapy 294ff secretory processes 80ff red blood cell invasion
cuticle composition and tubovesicular membrane system 80 malaria proteases and 92ff
transglutaminases 295ff Plasmodium chabaudi resistance see drug resistance
cysteine proteases 295 cytokines and 39, 333 (L) reverse genetics 349
enzymes 294ff merozoites 94,95 Rhipicephalus spp 13
moulting 294ff Plasmodium cynomolgi Rhipicephalus appendiculatus
onchocerciasis cytokines and 39 distribution in Africa 269
control 76ff, 294ff Plasmodium falciparum ribosomal P proteins
immunodiagnostic tests 76ff antigens 1ff, 18 (L) Trypanosoma cruzi 381ff
recombinant antigens 77,79 antigenic variation 284 ribosomal RNA
organic acid excretion avian malaria and 247 processing in malarial parasites
helminths 58ff chloroquine resistance 105ff, 127 466ff, 467
Ostertagia ostertagi (L), 278ff risk factors
life cycle 139 clonal variation 282ff logistic regression model 419, 420
migration 37ff, 55 (L) crosscontamination of culture lines RNA processing in malarial parasites
population size 37ff, 55 (L) (L) 127 465ff
selection 37ff, 55 (L) cytokines and 39, (L) 56 RNA virus delivery system 444ff
oxamniquine FCR-3 (L) 127 ruminants
mechanism of action 163ff intra-erythrocytic membranes 98ff coccidiosis 239
resistance 162ff merozoite surface antigen-I _50ff pharmacokinetic disposition of
structure 163 merozoite surface proteins 92ff gastrointestinal tract 329ff
merozoites 94
nates
P multi-drug-resistant phenotype S
Parascaris univalens 278ff sandflies see Phlebotomus spp
chromatin diminution 320 pathogenesis 281ff satellite data collection 437ff
parasite evolution phenotypic plasticity 281 ff SbV drugs 150ff
mathematical modelling 397 protection 281ff Schistosoma mansoni
parasite expulsion secretory transport 98ff prevalence estimation 305ff
epithelial ion transport 141ff strain identification 303ff schistosomes
parasite transmission Plasmodium knowles . DNA fingerprinting 289ff
chitinase and 252ff merozoites 94 drug resistance 162ff
parasite—vector interactions 45ff Plasmodium malariae genetics 164
molecular interactions 45ff phylogeny 248 hybridization 288
parasites Plasmodium ovale interactions with snails 235ff
positive effects on hosts 462 phylogeny 249 molecular analysis of populations
trafficking across vector midgut Plasmodium vivax 286ff
barriers 46ff simian malaria 247ff phylogeny 286, 288ff
tropisms in arthropod vectors 45ff Plasmodium yoelii randomly amplified polymorphic |
types, definition 476ff antibody response in mice (L) 96 DNA analysis 289 \
parasitism Pneumocystis carini ribosomal RNA gene complex 287ff
mutualism and 458ff atovaquone therapy 67ff sex-specific markers 290